TLC BioSciences Corp. (TPEX:7924)
Taiwan · Delayed Price · Currency is TWD 195.50
-15.00 (-7.13%)
At close: Jul 29, 2026
TLC BioSciences Market Cap
TLC BioSciences has a market cap or net worth of 28.85 billion as of July 29, 2026.
Market Cap
28.85B
Enterprise Value
29.11B
Revenue
89.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
195.50
ChartMarket Cap Chart
Since June 26, 2026, TLC BioSciences's market cap has increased from 28.11B to 28.85B, an increase of 2.61%. That is a compound annual growth rate of 33.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 28.85B | 2.61% |
| Jul 28, 2026 | 28.11B | -1.41% |
| Jul 27, 2026 | 28.52B | -1.16% |
| Jul 24, 2026 | 28.85B | - |
| Jul 23, 2026 | 28.85B | -6.09% |
| Jul 22, 2026 | 30.72B | 6.48% |
| Jul 21, 2026 | 28.85B | 7.46% |
| Jul 20, 2026 | 26.85B | -8.01% |
| Jul 17, 2026 | 29.18B | -6.62% |
| Jul 16, 2026 | 31.25B | 1.08% |
| Jul 15, 2026 | 30.92B | 0.22% |
| Jul 14, 2026 | 30.85B | -5.91% |
| Jul 13, 2026 | 32.79B | -0.20% |
| Jul 9, 2026 | 32.86B | -1.80% |
| Jul 8, 2026 | 33.46B | -4.75% |
| Jul 7, 2026 | 35.13B | 8.68% |
| Jul 6, 2026 | 32.32B | -3.59% |
| Jul 3, 2026 | 33.52B | 48.52% |
| Jul 2, 2026 | 22.57B | -4.52% |
| Jul 1, 2026 | 23.64B | -8.05% |
| Jun 30, 2026 | 25.71B | -10.26% |
| Jun 29, 2026 | 28.65B | 1.90% |
| Jun 26, 2026 | 28.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 18.23B |
| Elixiron Immunotherapeutics (Cayman) Limited | 10.98B |
| Intelligene | 7.05B |
| Uwell Biopharma | 6.83B |
| Tripartite Therapeutics | 5.92B |
| Obigen Pharma | 3.85B |
| Pet Pharm Biotech | 2.79B |
| BIONET Therapeutics | 2.16B |